SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today reported financial results for the fourth quarter and ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Birgitta Böckeler, Distinguished Engineer at ...

Thank you for standing by and welcome to the Fourth Quarter 2021 Codex DNA Earnings Conference Call. [Operator Instructions] I would now like to hand the conference to our Director of Investor ...

Good day, and thank you for standing by. Welcome to the second-quarter 2021 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there ...

OpenAI LLC today launched the private beta program for an artificial intelligence system dubbed Codex that can write software and perform data science tasks in response to natural-language prompts.

-- Acquisition will allow Codex DNA to expand its commercial BioXp™ system and biofoundry service offerings, reduce raw material costs, and accelerate overall growth strategy -- SAN DIEGO, Nov. 09, ...

In the beginning, computer programmers translated their desires into the language of machines. Now, those machines are becoming conversant in the language of their programmers. OpenAI's newly released ...

OpenAI's "Codex" AI model is back, in a new form from the 2021 offering that powered the original GitHub Copilot and kickstarted the GenAI craze. Rather, the new Codex, now in research preview, is ...

Codex DNA, fresh off raising $122 million in an initial public stock offering in June, has inked a deal to buy privately held Eton Bioscience — combining two of San Diego’s synthetic biology tools and ...

The company's share price blasted 39% higher because of an exciting new partnership. Under the terms of the deal, the two companies will work together to further develop Codex DNA's BioXP, which its ...